SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-016278
Filing Date
2024-06-10
Accepted
2024-06-10 18:42:49
Documents
1
Period of Report
2024-06-06

Document Format Files

Seq Description Document Type Size
1 form4-06102024_100645.html 4  
1 form4-06102024_100645.xml 4 8182
  Complete submission text file 0001415889-24-016278.txt   10074
Mailing Address 55 CAMBRIDGE PARKWAY SUITE 901E CAMBRIDGE MA 02142
Business Address 55 CAMBRIDGE PARKWAY SUITE 901E CAMBRIDGE MA 02142 (857) 999-0075
KalVista Pharmaceuticals, Inc. (Issuer) CIK: 0001348911 (see all company filings)

IRS No.: 200915291 | State of Incorp.: DE | Fiscal Year End: 0430
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O KALVISTA PHARMACEUTICALS, INC. ONE KENDALL SQUARE, BLD 200, STE 2203 CAMBRIDGE MA 02139
Business Address
Palleiko Benjamin L (Reporting) CIK: 0001366244 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36830 | Film No.: 241034160